Peter N Kellogg insider trades

Open-market stock purchases and sales by Peter N Kellogg, Director at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since May 7, 2010.

Recent trades

DateStockTradeValue
May 20, 2026ALNY Alnylam Pharmaceuticals, IncBought (not open market)—
May 20, 2026ALNY Alnylam Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ALNY Alnylam Pharmaceuticals, Inc: other filings, last May 20, 2026
  • YTEN Yield10 Bioscience, Inc: other filings, last May 22, 2019
  • CELG Celgene Corp /de/: other filings, last Jul 30, 2018
  • MBLX Metabolix, Inc: other filings, last Sep 10, 2015
  • MRK Merck & Co Inc: 5 buys, last Feb 24, 2014

Get free alerts when Peter N Kellogg files a new trade →